AIG
ERNA icon

American International Group’s Eterna Therapeutics ERNA Stock Holding History

American International Group’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2
Closed -$30K – 3145
2022
Q1 		$30K Hold
2
– – ﹤0.01% 2977
2021
Q4 		$66K Hold
2
– – ﹤0.01% 2871
2021
Q3 		$151K Hold
2
– – ﹤0.01% 2591
2021
Q2 		$240 Buy
+2
New +$288K ﹤0.01% 2385

Other funds holding ERNA

CPWM
Cypress Point Wealth Management Dallas, Texas $492M AUM 22.57% 1-Year Est. Return
NW
Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

American International Group's ERNA Position: Q2 2022 in Review

American International Group sold out of Eterna Therapeutics (ERNA) in Q2 2022, closing a stake of 2 shares — an estimated $30K sold.

American International Group first reported a position in ERNA in Q2 2021 and held it in 4 quarters. The position peaked at $151K in Q3 2021. 34 funds tracked by Wall St. Rank hold ERNA as of Q2 2022.

  • American International Group reported no remaining Eterna Therapeutics position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 2 Eterna Therapeutics shares in Q2 2022, an estimated $30K.
  • American International Group first reported a position in Eterna Therapeutics in Q2 2021 and held it in 4 quarters.
  • American International Group's Eterna Therapeutics position peaked at $151K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.